ArticleFrontiers in immunology2026

Case Report: Successful treatment of recurrent COVID-19 with intravenous immunoglobulin in a patient with rituximab-induced B-cell depletion and restoration of Fc-mediated effector functions.

Hee Bum Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.